Obesity, Morbid Clinical Trial
— ETOOfficial title:
Impact of Endoscopic Gastric Reduction of Ghrelin Receptors Rich Gastric Mucosa on Obesity and Metabolic Syndrome: a Randomized Controlled Trial
NCT number | NCT06231251 |
Other study ID # | 9352 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | December 1, 2023 |
Est. completion date | December 1, 2024 |
In the stomach, the ghrelin-containing cells are more abundant in the fundus than in the pylorus originally termed X/A-like cells. These X/A-like cells account for approximately 20 % of the endocrine cell population in adult oxyntic glands. Ghrelin enhances the secretion of growth hormone, the stimulation of appetite and food intake, the modulation of gastric acid secretion & motility and the endocrine and exocrine pancreatic secretions.
Status | Recruiting |
Enrollment | 48 |
Est. completion date | December 1, 2024 |
Est. primary completion date | September 13, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - body mass index more than 25 - diagnosis of diabetes mellitus. - diagnosis of cardio-metabolic syndrome. - fatty liver disease diagnosed by abdominal ultrasound. Exclusion Criteria: - use of drugs which induce insulin resistance, diabetes and hepatic steatosis. - excess alcohol consumption. - chronic gastritis, active peptic ulcer. - malignancy. - depression and severe psychological disorders - inability to give informed consent. - coagulopathy (INR more than 1.5, platelets less than 50000 per cmm). - severe cardiopulmonary comorbidity. |
Country | Name | City | State |
---|---|---|---|
Egypt | Zagazig University | Zagazig | Sharkia |
Lead Sponsor | Collaborator |
---|---|
Zagazig University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of patients with improved insulin resistance | significant decrease in insulin resistance through assessing Homeostatic Model Assessment for Insulin Resistance, calculated by using the following formula: fasting glucose (mg/dL) X fasting insulin (µU/mL) / 405 | 6 months | |
Primary | Number of patients with significant weight reduction | significant weight reduction of more than 10% of baseline body weight measured in kilograms | 6 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04517591 -
Reducing Sedentary Time in Bariatric: The Take a STAND for Health Study
|
N/A | |
Active, not recruiting |
NCT04583683 -
Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities
|
N/A | |
Completed |
NCT01550601 -
Impact of the Preservation of the Gastric Antrum in the Technique of Sleeve Gastrectomy for the Treatment of the Morbid Obesity
|
N/A | |
Completed |
NCT03638843 -
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
|
N/A | |
Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
Completed |
NCT03339791 -
Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT05711758 -
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
|
||
Not yet recruiting |
NCT04209842 -
Effectiveness Gastric Balloon in Obese Adolescents
|
N/A | |
Recruiting |
NCT03100292 -
Korean OBEsity Surgical Treatment Study
|
N/A | |
Active, not recruiting |
NCT04357119 -
Common Limb Length in One-anastomosis Gastric Bypass
|
N/A | |
Completed |
NCT03210207 -
Gastric Plication in Mexican Patients
|
N/A | |
Completed |
NCT02590406 -
EPO2-A: Evaluation of Pre-Oxygenation in Morbid Obesity: Effect of Position and Positive Pressure Ventilation
|
N/A | |
Completed |
NCT01840020 -
BAR-trial: Bioavailability of Ethanol Following Bariatric Surgery
|
||
Completed |
NCT01183975 -
Swedish Adjustable Gastric Banding Observational Cohort Study
|
N/A | |
Completed |
NCT03872024 -
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients
|
N/A | |
Terminated |
NCT05993169 -
Body Composition Optimization Intervention RCT
|
N/A | |
Not yet recruiting |
NCT05974995 -
Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer
|
N/A | |
Recruiting |
NCT05554016 -
The UFO (Ultra Processed Foods in Obesity) Project
|
||
Completed |
NCT05519423 -
Investigation of the Effectiveness of Whatsapp-Based Physical Activity Incentive Program in Morbidly Obese Individuals
|
N/A | |
Not yet recruiting |
NCT05499949 -
The Franciscus Obesity NASH Study
|